(3S,6R)-Lateritin exhibits promising biological activity, particularly in antimicrobial and antifungal applications. It has been studied for its ability to inhibit the growth of certain Gram-positive bacteria and pathogenic fungi, making it a candidate for development in anti-infective therapies. Its unique stereochemistry contributes to membrane-targeting properties, potentially disrupting microbial cell integrity with limited toxicity to mammalian cells. Additionally, (3S,6R)-Lateritin has shown moderate cytotoxic effects against select cancer cell lines, suggesting possible utility in oncology research. Due to its natural origin and selective bioactivity, it is also used as a lead compound in the synthesis of novel derivatives for drug discovery.